ASH

News

Celgene scores at ASH18 with double luspatercept data

A pair of clinical trial wins for Celgene’s luspatercept at the American Society of Haematology (ASH) meeting have set up a filing for the new drug in mid-2019.

News

Spark reassures on safety of haemophilia gene therapy

Study of nine patients produce encouraging results

News

As rituximab biosimilars close in, Roche showcases Gazyva su...

Roche faces competition against its blockbuster haematology drug

News

The ASH congress is one again being held in San Diego.

CAR-Ts to take centre stage at ASH haematology congress

Haematology is one of the most exciting areas in drug development today, with waves of new treatments emerging for hard-to-treat diseases.

Celgene scores at ASH18 with double luspatercept data

Spark reassures on safety of haemophilia gene therapy

As rituximab biosimilars close in, Roche showcases Gazyva su...

CAR-Ts to take centre stage at ASH haematology congress

ASCO 2026: Chinese firms take a front seat in oncology, with...

Discover a new era of healthcare panel engagement: Grounded ...

ASH

Editor's Picks